Also, immunofluorescence (IF) and flow cytometry analyses revealed that PRMT3 inhibition led to a robust increase in the abundance of tumor-infiltrating CD4+ and CD8+ T cells, including IFNγ + CD8+ and GZMB+ CD8+ T cells (Fig. 3S–U). This evidence concerns the gene PRMT3 and neoplasm.